FY2024
-
Updated "Research and Development Pipeline."
-
Consolidated Financial Results(3Q/Apr-Dec FY2024)
-
Tillotts Pharma partners with Pioneer for the marketing and distribution of Asacol
-
Updated "Research and Development Pipeline."
-
Consolidated Financial Results(2Q/Apr-Sep FY2024)
-
Updated "Research and Development Pipeline."
-
Consolidated Financial Results(1Q/Apr-Jun FY2024)
-
Zeria Pharmaceutical and Agastra-Lab announces reaching Agreement for the Development of Acotiamide.
-
Updated "Research and Development Pipeline."
-
Consolidated Financial Results (for the Fiscal Year Ended March 31, 2024)